Retraction
CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells
Paper Information
Record ID:
50204
Author(s):
Journal:
Publication Date:
April 11, 2020
Retraction Date:
December 10, 2023
(2.0 year years ago)
Subjects:
Institutions:
- Department of Neurosurgery, Xingtai People’s Hospital, Xingtai, China
- Department of Neurosurgery, The First People's Hospital of Shenyang, Shenyang, China
- Department of Operating Room, Xingtai People’s Hospital, Xingtai, China
- Department of Intensive Care Unit, Xingtai People’s Hospital, Xingtai, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Wiley
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (35)
35
Total Citations6
Post-Retraction(17.1%)
29
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
5
Within 1 year
0
After 2+ years
388
Days since retraction (latest)
Unusual presentation of luminal breast carcinoma metastatic to the brain and coma: a case report of dramatic response to abemaciclib and literature review
Maria Rosaria Valerio, Calogero Cipolla, Martina Greco et al. (8 authors)
Therapeutic Advances in Medical Oncology
Open Access
Published: Jan 2025
388 days after retraction
Paper citing CDK4/6 inhibition suppresses tumour growth and enh...
Unknown Authors
Unknown Journal
Published: Dec 2024
362 days after retraction
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I)
Margaret E. Macy, Rajen Mody, Joel M. Reid et al. (20 authors)
JCO Precision Oncology
Published: Sep 2024
4 citations
4 citations
266 days after retraction
Proteomics Analysis of Interactions between Drug-Resistant and Drug-Sensitive Cancer Cells: Comparative Studies of Monoculture and Coculture Cell Systems
Zongkai Peng, Nagib Ahsan, Zhibo Yang
Journal of Proteome Research
Published: Jun 2024
4 citations
4 citations
195 days after retraction
Involvement of the tumour necrosis factor receptor system in glioblastoma cell death induced by palbociclib-heptamethine cyanine dye conjugate
Elizabeth Cooper, Caitlin R. M. Oyagawa, Rebecca Johnson et al. (15 authors)
Cell Communication and Signaling
Open Access
Published: Jan 2024
1 citation
1 citation
32 days after retraction
Enhancing drug delivery with supramolecular amphiphilic macrocycle nanoparticles: selective targeting of CDK4/6 inhibitor palbociclib to melanoma
Mohamed F. Attia, Edikan A. Ogunnaike, Megan Pitz et al. (9 authors)
Biomaterials Science
Open Access
Published: Dec 2023
2 citations
2 citations
1 days after retraction
Enhancing Drug Delivery with Supramolecular Amphiphilic Macrocycle Nanoparticles: Selective Targeting of CDK4/6 Inhibitor Palbociclib to Melanoma
Mohamed F. Attia, Edikan A. Ogunnaike, Megan Pitz et al. (9 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Nov 2023
19 days before retraction
Liquid biopsy: creating opportunities in brain space
Rakesh Trivedi, Krishna Bhat
British Journal of Cancer
Open Access
Published: Sep 2023
10 citations
10 citations
75 days before retraction
Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment
Smita Kumari, Pravir Kumar
Frontiers in Cell and Developmental Biology
Open Access
Published: Jul 2023
5 citations
5 citations
144 days before retraction
Targeting AXL in mesothelioma: From functional characterization to clinical implication
Kinjal Bhadresha, Sheefa Mirza, Clement Penny et al. (4 authors)
Critical Reviews in Oncology/Hematology
Published: Jun 2023
2 citations
2 citations
192 days before retraction
An online survival predictor in glioma patients using machine learning based on WHO CNS5 data
Liguo Ye, Lingui Gu, Zhiyao Zheng et al. (20 authors)
Frontiers in Neurology
Open Access
Published: May 2023
7 citations
7 citations
205 days before retraction
Comparison of Oncogenes, Tumor Suppressors, and MicroRNAs Between Schizophrenia and Glioma: The Balance of Power
James S. Brown
Neuroscience & Biobehavioral Reviews
Published: May 2023
4 citations
4 citations
213 days before retraction
Retraction Note: Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer
Xiao Tan, Zhongqiang Zhang, Ping Liu et al. (6 authors)
Cell Death and Disease
Open Access
Published: Mar 2023
1 citation
1 citation
256 days before retraction
Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario
Marina Ferreira Cândido, Mariana Medeiros, Luciana Chain Veronez et al. (8 authors)
Pharmaceutics
Open Access
Published: Feb 2023
6 citations
6 citations
297 days before retraction
Molecular Heterogeneity in BRAF-Mutant Gliomas: Diagnostic, Prognostic, and Therapeutic Implications
Benoît Lhermitte, Thibaut Wolf, Marie Pierre Chenard et al. (16 authors)
Cancers
Open Access
Published: Feb 2023
8 citations
8 citations
297 days before retraction
A Novel Insight into Paraptosis-Related Classification and Signature in Lower-Grade Gliomas
Xifeng Qian, Jiahao Zhang, Yuexue Mai et al. (8 authors)
International Journal of Genomics
Open Access
Published: Nov 2022
8 citations
8 citations
391 days before retraction
Identification of a Fibroblast-Related Prognostic Model in Glioma Based on Bioinformatics Methods
Haofuzi Zhang, Yutao Huang, Erwan Yang et al. (15 authors)
Biomolecules
Open Access
Published: Oct 2022
13 citations
13 citations
406 days before retraction
A review on the role of cyclin dependent kinases in cancers
Soudeh Ghafouri‐Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen et al. (8 authors)
Cancer Cell International
Open Access
Published: Oct 2022
89 citations
89 citations
416 days before retraction
Resistance to CDK4/6 inhibition: Mechanisms and strategies to overcome a therapeutic problem in the treatment of hormone receptor-positive metastatic breast cancer
Marios Papadimitriou, Anastasia Pazaiti, Konstantinos Iliakopoulos et al. (6 authors)
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Open Access
Published: Aug 2022
45 citations
45 citations
473 days before retraction
Investigational cyclin-dependent kinase 4/6 inhibitor GLR2007 demonstrates activity against isocitrate dehydrogenase wild-type glioblastoma and other solid tumors in mice xenograft models
Lei Yin, Zhenglin Yao, Yue Wang et al. (4 authors)
Frontiers in Oncology
Open Access
Published: Aug 2022
486 days before retraction
Case Report: Clinicopathological and Genetic Features of IDH-Mutant Brainstem Glioma in Adults: Report of Five Cases
Jiangfen Zhou, Mingyao Lai, Yang Ni et al. (9 authors)
Pathology & Oncology Research
Open Access
Published: Aug 2022
7 citations
7 citations
493 days before retraction
A Radiologist’s Guide to the 2021 WHO Central Nervous System Tumor Classification: Part I—Key Concepts and the Spectrum of Diffuse Gliomas
Derek R. Johnson, Caterina Giannini, Rachael A. Vaubel et al. (7 authors)
Radiology
Published: Jul 2022
31 citations
31 citations
502 days before retraction
Molecular mechanisms of drug resistance of glial tumor of brain. Part 2: Proliferation, angiogenesis, metastasis and recurrency
Alexander N. Chernov, Elvira S. Galimova, Olga V. Shamova
Medical academic journal
Published: Jul 2022
509 days before retraction
Small Molecule Inhibitors in Adult High-Grade Glioma: From the Past to the Future
Wenda Huang, Zhaonian Hao, Feng Mao et al. (4 authors)
Frontiers in Oncology
Open Access
Published: Jun 2022
14 citations
14 citations
541 days before retraction
Promising Chemotherapy for Malignant Pediatric Brain Tumor in Recent Biological Insights
Qian Zhou, Yichen Xu, Yan Zhou et al. (4 authors)
Molecules
Open Access
Published: Apr 2022
5 citations
5 citations
598 days before retraction
An oncogenic splice variant of PDGFRα in adult glioblastoma as a therapeutic target for selective CDK4/6 inhibitors
Taiji Hamada, Toshiaki Akahane, Seiya Yokoyama et al. (9 authors)
Scientific Reports
Open Access
Published: Jan 2022
8 citations
8 citations
685 days before retraction
Condition Medium of Glioblastoma Cell Lines Decreases the Viability of Glioblastoma Cells by Modulating Gene Expression Profile
Mervenur Yavuz, Sıddıka Akgül, Egemen Kaya et al. (4 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Sep 2021
2 citations
2 citations
819 days before retraction
Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial
Francisco Bautista, Xavier Paolettí, Jonathan Rubino et al. (17 authors)
Journal of Clinical Oncology
Published: Aug 2021
15 citations
15 citations
858 days before retraction
In vitro therapeutic effects of abemaciclib on triple‐negative breast cancer cells
Zeynep Özman, Gamze Güney Eskiler, Mehmet Ramazan Şekeroğlu
Journal of Biochemical and Molecular Toxicology
Published: Jul 2021
7 citations
7 citations
867 days before retraction
The function and mechanism of the JARID2/CCND1 axis in modulating glioma cell growth and sensitivity to temozolomide (TMZ)
Weilu Kuang, Wuzhong Jiang, Yinyun Chen et al. (5 authors)
Cancer Biology & Therapy
Open Access
Published: Jun 2021
6 citations
6 citations
920 days before retraction
A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials
Elisabete Cruz Da Silva, Marie-Cécile Mercier, Nelly Étienne-Selloum et al. (5 authors)
Cancers
Open Access
Published: Apr 2021
102 citations
102 citations
975 days before retraction
Medulloblastoma drugs in development: Current leads, trials and drawbacks
Jiachen Wen, M. Kyle Hadden
European Journal of Medicinal Chemistry
Open Access
Published: Feb 2021
16 citations
16 citations
1035 days before retraction
Updated Insights on EGFR Signaling Pathways in Glioma
Alexandru Opriţa, Stefania-Carina Baloi, Georgiana-Adeline Staicu et al. (8 authors)
International Journal of Molecular Sciences
Open Access
Published: Jan 2021
132 citations
132 citations
1066 days before retraction
<i>Retracted:</i> CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells
Yingxiao Cao, Xin Li, Shiqi Kong et al. (5 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Apr 2020
34 citations
34 citations
1338 days before retraction
Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway
Xiao Yu, Maode Wang, Jie Zuo et al. (9 authors)
Life Sciences
Open Access
Published: Oct 2019
23 citations
23 citations
1520 days before retraction
Quick Stats
Total Citations:
35
Years Since Retraction:
2.0 year
Open Access:
Yes
Last Checked:
Jul 24, 2025